GSE182150 KIT LSD1 MYC inhibition 6 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE182150_KIT_LSD1_MYC inhibition_6_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE182150_KIT_LSD1_MYC inhibition_6_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE182150_KIT_LSD1_MYC inhibition_6_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE182150_KIT_LSD1_MYC inhibition_6_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 1

Gene

small nucleolar RNA host gene 29

Gene

mitochondrial ribosomal protein L45

Gene

ZNFX1 antisense RNA 1

Gene

RNA polymerase II subunit J3

Gene

MT-CO2 pseudogene 12

Gene

MIR1915 host gene

Gene

deleted in lymphocytic leukemia 2

Gene

hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA

Gene

MT-ND2 pseudogene 28

  • Gene

    small nucleolar RNA host gene 1


  • Gene

    small nucleolar RNA host gene 29


  • Gene

    mitochondrial ribosomal protein L45


  • Gene

    ZNFX1 antisense RNA 1


  • Gene

    RNA polymerase II subunit J3


  • Gene

    MT-CO2 pseudogene 12



  • Gene

    deleted in lymphocytic leukemia 2


  • Gene

    hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA


  • Gene

    MT-ND2 pseudogene 28

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.